Adam Dubow serves as the General Counsel and Chief Compliance Officer at Day One Biopharmaceuticals, Inc., a biopharmaceutical company focused on developing targeted therapies for patients with genetically defined cancers. In his role, Dubow is responsible for overseeing the company's legal affairs, ensuring compliance with regulatory requirements, and providing strategic guidance to the executive team. His expertise in corporate governance, securities law, and healthcare regulations has been instrumental in navigating the complex landscape of the biopharmaceutical industry. Prior to joining Day One Biopharmaceuticals, Dubow held several high-level positions at leading biotechnology and pharmaceutical companies. He served as Vice President and General Counsel at Tricida, Inc., where he played a key role in the company's initial public offering and subsequent growth. Before that, he was Associate General Counsel at Allergan, where he managed a wide range of legal matters, including mergers and acquisitions, intellectual property, and litigation. Dubow began his career as an attorney at Latham & Watkins LLP, a prominent international law firm, where he advised clients on various corporate and securities law matters. Dubow's achievements in the field of biopharmaceutical law have earned him recognition as a trusted advisor and leader in the industry. His strategic vision and commitment to ethical business practices have been vital to Day One Biopharmaceuticals' mission of bringing innovative therapies to patients in need. As the company continues to advance its pipeline of targeted cancer treatments, Dubow's leadership will be crucial in ensuring that Day One Biopharmaceuticals remains at the forefront of the industry while maintaining the highest standards of compliance and corporate governance.